Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04240704` - Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL	Phase 1
Active, not recruiting	`NCT04188678` - Resiliency in Older Adults Undergoing Bone Marrow Transplant	N/A
Recruiting	`NCT00807196` - Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma	Phase 1/Phase 2
Completed	`NCT00764829` - Blood Samples to Evaluate Biomarkers of Donor Chimerism	N/A
Completed	`NCT00726934` - The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients	N/A
Completed	`NCT01517581` - Brown Fat Activity and White Fat Accumulation	N/A
Completed	`NCT00193505` - Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma	Phase 2
Terminated	`NCT01744912` - Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies	Phase 1
Terminated	`NCT01500161` - Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match	Phase 2
Active, not recruiting	`NCT03533283` - An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma	Phase 1/Phase 2
Active, not recruiting	`NCT00001379` - Treatment and Natural History Study of Lymphomatoid Granulomatosis	Phase 2
Completed	`NCT00574730` - CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma	N/A
Completed	`NCT00901225` - Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant	Phase 2
Terminated	`NCT01598025` - Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor	N/A
Terminated	`NCT01326728` - Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
Completed	`NCT01290549` - A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma	Phase 1
Completed	`NCT00807677` - A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies	Phase 1
Completed	`NCT00837200` - Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies	Phase 2
Terminated	`NCT00003500` - Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma	Phase 2
Active, not recruiting	`NCT02099266` - Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment	N/A

NCT number	NCT00054834
Study type	Interventional
Source	Gilead Sciences
Contact
Status	Terminated
Phase	Phase 1
Start date	March 2003

Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms